Globeflex Capital’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Globeflex Capital's HALO Position: Q1 2026 in Review
Globeflex Capital sold out of Halozyme (HALO) in Q1 2026, closing a stake of 31,808 shares — an estimated $2.14M sold.
Globeflex Capital first reported a position in HALO in Q2 2015 and held it in 26 quarters. The position peaked at $2.33M in Q3 2025. 637 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Globeflex Capital reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
- Globeflex Capital sold 31,808 Halozyme shares in Q1 2026, an estimated $2.14M.
- Globeflex Capital first reported a position in Halozyme in Q2 2015 and held it in 26 quarters.
- Globeflex Capital's Halozyme position peaked at $2.33M in Q3 2025.
- 637 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.